STERIS’ (TSE:STE – Free Report) – Equities research analysts at Raymond James cut their FY2024 earnings per share (EPS) estimates for shares of STERIS’ in a report released on Tuesday, October 15th. Raymond James analyst M. Barth now expects that the company will post earnings of $0.77 per share for the year, down from their previous forecast of $0.99.
STERIS’ Stock Performance
STERIS’ (TSE:STE – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The company had revenue of C$231.38 million during the quarter, compared to analysts’ expectations of C$226.20 million.
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- The Basics of Support and Resistance
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- What Does a Stock Split Mean?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Investing in Construction Stocks
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
